Rigel Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $5.9M | $5.3M | $627.0K | $9.5M |
| FY2022 | $-73.8M | $-74.2M | $450.0K | $12.4M |
| FY2023 | $-5.7M | $-5.7M | — | $8.8M |
| FY2024 | $31.5M | $31.5M | — | $12.4M |
| FY2025 | $75.7M | $75.7M | — | $12.7M |